Data compiled by Redley Lamar · ChainSifter Intelligence
5Suppliers
8Customers
1Debt Items
0Related Chains
Source-Backed Evidence Depth
Advanced Biomed Inc. (ADVB) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
16Total relationships
5Distinct source URLs
10High confidence
0.798Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Advanced Biomed Inc. Suppliers
Ticker
Name
Confidence
Evidence
ACELLENT-TECHNOLOGIES-HONG-KONG-CO-LIMITED
ACELLENT-TECHNOLOGIES-HONG-KONG-CO-LIMITED
92%
the Company entered into a Share Purchase Agreement with Acellent Technologies (Hong Kong) Co. Limited (the 'Target')
ADVANCED-BIOMED-HK-LIMITED
ADVANCED-BIOMED-HK-LIMITED
92%
Advanced Biomed (HK) Limited acknowledged and agreed that, as of the date of the Spin-Off Agreement and as of the date of the Supplemental Agreement, Advanced Biomed (HK) Limited was and is indebted …
JIE-WANG
JIE-WANG
92%
On April 13, 2026, Advanced Biomed Inc. (the “Company”) entered into a Loan Agreement (the “Loan Agreement”) with Jie Wang (the “Lender”), pursuant to which the Lender lent to the Company a principal…
XIAOMIN-CHEN
XIAOMIN-CHEN
92%
Mr. Xiaomin Chen, as the sole shareholder of the Target, was a party to the Share Purchase Agreement
SHANGHAI-SGLCELL-BIOTECH-CO-LTD
SHANGHAI-SGLCELL-BIOTECH-CO-LTD
90%
all intellectual property owned by the Hong Kong subsidiary, including intellectual property owned by Shanghai Sglcell Biotech Co., Ltd., a wholly owned subsidiary of the Hong Kong subsidiary, was tr…
Advanced Biomed Inc. Customers
Ticker
Name
Confidence
Evidence
WEI-HA-HUI
WEI-HA-HUI
92%
the Company agreed to sell 100% of the issued and outstanding shares of Advanced Biomed (HK) Limited, a Hong Kong company and a wholly owned subsidiary of the Company, for an aggregate purchase price…
XIAOMIN-CHEN
XIAOMIN-CHEN
90%
the Company entered into an employment agreement with Xiaomin Chen, pursuant to which Mr. Chen shall receive compensation at the rate of $12,000 per month
ADVANCED-BIOMED-HK-LIMITED
ADVANCED-BIOMED-HK-LIMITED
62%
he Company obtained the approval of the Investment Commission of the Ministry of Economic Affairs (“Taiwan Investment Commission”) for the reorganization, and the issuance number of which is “ 經審一字第 …
CENTRAL-DEPOSIT-INSURANCE-CORPORATION
CENTRAL-DEPOSIT-INSURANCE-CORPORATION
62%
s ended March 31, 2026 and 2025 For the nine-month periods ended March 31, Change 2026 2025 US$ US$ US$ % Operating expenses: Research and development expenses (665,140 ) (600,056 ) (65,084 ) 11 % Ge…
HK-LIMITED
HK-LIMITED
62%
ies and 48 healthy patients without lung nodules reported by imaging studies. 7ml blood samples were taken from test subjects either before the clinical operation (for cancer patients) or after the p…
HONG-KONG-CO-LIMITED
HONG-KONG-CO-LIMITED
62%
ies and 48 healthy patients without lung nodules reported by imaging studies. 7ml blood samples were taken from test subjects either before the clinical operation (for cancer patients) or after the p…
PRINCIPAL-ACTIVITIES-ADVANCED-BIOMED-INC
PRINCIPAL-ACTIVITIES-ADVANCED-BIOMED-INC
62%
he Company obtained the approval of the Investment Commission of the Ministry of Economic Affairs (“Taiwan Investment Commission”) for the reorganization, and the issuance number of which is “ 經審一字第 …
SHANGHAI-SGLCELL-BIOTECH-CO-LTD
SHANGHAI-SGLCELL-BIOTECH-CO-LTD
62%
ies and 48 healthy patients without lung nodules reported by imaging studies. 7ml blood samples were taken from test subjects either before the clinical operation (for cancer patients) or after the p…
Advanced Biomed Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
ADVB-DEBT
Debt stack $712,529
90%
Market cache reports total debt of $712,529.
Advanced Biomed Inc. Acquisitions
Acquired Entity
Name
Confidence
Evidence
ADVB-ACQ-0001213900-26-051028
The Company issued 270,000 shares of common stock to acquire 100% of the equity interest in Acel...
85%
The Company issued 270,000 shares of common stock to acquire 100% of the equity interest in Acellent Technologies.
Advanced Biomed Inc. Ownership
Holder
Name
Confidence
Evidence
ADVB-OWNER-XTX-TOPCO-LTD
XTX Topco Ltd
90%
13F overlay lists XTX Topco Ltd as top holder; 3 tracked holders.
Advanced Biomed Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
